Thrombotic effects on users of combined oral contraceptives throughout their fertile life: integrative review
DOI:
https://doi.org/10.33448/rsd-v9i11.10458Keywords:
Combined oral contraceptives; Fertile age; Thrombotic effects.Abstract
Combined hormonal contraceptives (CHC) are used among women of the wordwide, increasing the risk of venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE). The objective was to identify studs with thrombotic effects in women of child-bearing age associated with the use of combined oral contraceptives. The methodology used was an integrative review of the PubMed database articles using the health descriptors: “combined oral contraceptives”, “thrombotic effects”, “blood clot”, and Portuguese version. The result found in the article showed that the continuous and prolonged use of CHC increase the risk of platelet aggregation and low thrombolysis favoring the formation of thrombi, resulting in accentuated DVT developtment. Thus, it is important to observe the medical eligibility criteria to define use of CHC for patients taking into account the risks a thrombotic disorder.
References
Brandt, G. P., Oliveira, A. P. R., & Burci, L. M. (2018). Anticoncepcionais hormonais na atualidade: um novo paradigma para o planejamento familiar. RGS, 18(1), 54–62.
Emmerson, O., Bester, J., Lindeque, B. G., & Swanepoel, A. C. (2018). The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes. Microscopy and Microanalysis, 24(6), 713–728. https://doi.org/10.1017/S1431927618015453
Gialeraki, A., Valsami, S., Pittaras, T., Panayiotakopoulos, G., & Politou, M. (2018). Oral Contraceptives and HRT Risk of Thrombosis. Clinical and Applied Thrombosis/Hemostasis, 24(2), 217–225. https://doi.org/10.1177/1076029616683802
Heit, J. A., Spencer, F. A., & White, R. H. (2016). The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis, 41(1), 3–14. https://doi.org/10.1007/s11239-015-1311-6
Hugon-Rodin, J., Alhenc-Gelas, M., Hemker, H. C., Brailly-Tabard, S., Guiochon-Mantel, A., Plu-Bureau, G., & Scarabin, P.-Y. (2017). Sex hormone-binding globulin and thrombin generation in women using hormonal contraception. Biomarkers, 22(1), 81–85. https://doi.org/10.1080/1354750X.2016.1204010
Hugon-Rodin, J., Horellou, M.-H., Conard, J., Gompel, A., & Plu-Bureau, G. (2018). Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism. Thrombosis and Haemostasis, 118(05), 922–928. https://doi.org/10.1055/s-0038-1641152
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Bouma, B. N., & Grobbee, D. E. (2002). Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Thrombosis and Haemostasis, 87(2), 199–205. http://www.ncbi.nlm.nih.gov/pubmed/11859850
Kobayashi, T., Sugiura, K., & Ojima, T. (2017). Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women. Journal of Obstetrics and Gynaecology Research, 43(5), 789–797. https://doi.org/10.1111/jog.13304
Köche, J. C. (2011). Fundamentos de metodologia científica: teoria da ciência e iniciação à pesquisa (Edição digital). Petrópolis, RJ. Vozes.
Lidegaard, Ø. (2018). Severely biased review of studies assessing the risk of venous thrombosis in users of drospirenone-containing oral contraceptives. BJOG: An International Journal of Obstetrics & Gynaecology, 125(8), 929–931. https://doi.org/10.1111/1471-0528.15211
Lorenzi, T. (2006). Manual de hematologia: propedêutica e clínica. (Guanabara Koogan (ed.); 4th ed.).
Machado, A. I., & Lima, J. (2008). Trombofilias e contracepção. Acta Obstet Ginecol Port., 2(2), 84–95.
McDaid, A., Logette, E., Buchillier, V., Muriset, M., Suchon, P., Pache, T. D., Tanackovic, G., Kutalik, Z., & Michaud, J. (2017). Risk prediction of developing venous thrombosis in combined oral contraceptive users. PLOS ONE, 12(7), e0182041. https://doi.org/10.1371/journal.pone.0182041
Oliveira, J. C. (2018). Tromboembolismo venoso associado ao uso de anticoncepcionais orais combinados: uma revisão da literatura.No Title [Faculdade de Ciências Farmacêuticas, Universidade de São Paulo]. http://bdta.aguia.usp.br/directbitstream/fc825039-bfc8-4aa5-a87f-ac45ff5a6b03/2954732.pdf
Pereira, A. S., Shitsuka, D. M., Parreira, F. J. & Shitsuka, R. (2018). Metodologia da pesquisa científica. Núcleo de Tecnologia Educacional. Santa Maria, RS. UFSM.
Park, M.-J., & Jeon, G.-H. (2017). Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel. Obstetrics & Gynecology Science, 60(2), 232. https://doi.org/10.5468/ogs.2017.60.2.232
Prado, S. D., & Santos, D. L. (2011). Contracepção em usuárias dos setores público e privado de saúde. Rev Bras Ginecol Obstet., 33(7), 143–149. https://doi.org/10.1590/S0100-72032011000700005
Reid, R., Leyland, N., Wolfman, W., Allaire, C., Awadalla, A., Best, C., Dunn, S., Lemyre, M., Marcoux, V., Menard, C., Potestio, F., Rittenberg, D., Singh, S., & Senikas, V. (2011). Oral contraceptives and the risk of venous thromboembolism: An update. International Journal of Gynecology & Obstetrics, 112(3), 252–256. https://doi.org/10.1016/j.ijgo.2010.12.003
Roach, R. E. J., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M. (2015). Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011054.pub2
Sandset, P. M. (2013). Mechanisms of hormonal therapy related thrombosis. Thrombosis Research, 131, S4–S7. https://doi.org/10.1016/S0049-3848(13)70009-4
Silva, J. E., Santana, K. D. S., Nunes, J. D. S., Santos, J. C. dos, & Terra Júnior, A. T. (2018). A relação entre o uso de anticoncepcionais orais e a ocorrência de trombose. Revista Científica FAEMA, 9(1), 383. https://doi.org/10.31072/rcf.v9i1.522
Sitruk-Ware, R. (2016). Hormonal contraception and thrombosis. Fertility and Sterility, 106(6), 1289–1294. https://doi.org/10.1016/j.fertnstert.2016.08.039
Souza, I. C. A., & Álvares, A. C. M. (2018). A trombose venosa profunda como reação adversa do uso contínuo de anticoncepcionais oraisNo Title. Científica Sena Aires, 2018; 7(1):54-65., 7(1), 54–65.
Stam-Slob, M. C., Lambalk, C. B., & van de Ree, M. A. (2015). Contraceptive and hormonal treatment options for women with history of venous thromboembolism. BMJ, 351, h4847. https://doi.org/10.1136/bmj.h4847
Stegeman, B. H., Vos, H. L., Helmerhorst, F. M., Rosendaal, F. R., Reitsma, P. H., & van Hylckama Vlieg, A. (2017). Genetic variation in the first-pass metabolism of ethinylestradiol, sex hormone binding globulin levels and venous thrombosis risk. European Journal of Internal Medicine, 42, 54–60. https://doi.org/10.1016/j.ejim.2017.05.019
Suchon, P., Al Frouh, F., Ibrahim, M., Sarlon, G., Venton, G., Alessi, M.-C., Trégouët, D.-A., & Morange, P.-E. (2017). Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study. Clinical Genetics, 91(1), 131–136. https://doi.org/10.1111/cge.12833
Sugiura, K., Kobayashi, T., & Ojima, T. (2016). Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women. Thrombosis Research, 137, 11–16. https://doi.org/10.1016/j.thromres.2015.11.038
Sugiura, K., Ojima, T., Urano, T., & Kobayashi, T. (2018). The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population. Journal of Obstetrics and Gynaecology Research, 44(9), 1766–1772. https://doi.org/10.1111/jog.13706
Swanepoel, A. C., Emmerson, O., & Pretorius, E. (2017). Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure. Microscopy and Microanalysis, 23(3), 607–617. https://doi.org/10.1017/S1431927617000484
Swanepoel, A. C., Visagie, A., & Pretorius, E. (2016). Synthetic Hormones and Clot Formation. Microscopy and Microanalysis, 22(4), 878–886. https://doi.org/10.1017/S1431927616011478
Tepper, N. K., Dragoman, M. V., Gaffield, M. E., & Curtis, K. M. (2017). Nonoral combined hormonal contraceptives and thromboembolism: a systematic review. Contraception, 95(2), 130–139. https://doi.org/10.1016/j.contraception.2016.10.005
United Nations. Department of Economic and Social Affairs. (2015). World contraceptive patterns 2015.
van Vlijmen, E. F. W., Wiewel-Verschueren, S., Monster, T. B. M., & Meijer, K. (2016). Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 14(7), 1393–1403. https://doi.org/10.1111/jth.13349
Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015). Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ (Clinical Research Ed.), 350, h2135. https://doi.org/10.1136/bmj.h2135
WHO. (2008). Reproductive Health and Research and John Hopkins Bloomberg School of Public Health. Family planning: a global handbook for providers (WHO (ed.)).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Mariana Queiroz Ortega; Raphaela Silva Cruz ; Lucas Giacomini Bernardi ; Maria Eduarda Delatore Braga ; Angélica Augusta Grigoli Dominato
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
